Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX)

Historical Holders from Q2 2023 to Q3 2025

Symbol
ELTX on Nasdaq
CUSIP
28657F103
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
16.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.9M
Holdings value
$20.8M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
27
Number of buys
19
Number of sells
-4
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GKCC, LLC 48% $115M 9.76M Yekaterina Chudnovsky Jun 3, 2025
Chudnovsky Yekaterina 48.1% $59.5M 9.66M Yekaterina Chudnovsky Mar 5, 2025
Knoll Capital Management, LLC 5.2% $3.89M 631K Knoll Capital Management, LLC Jan 30, 2025
Actyus Private Equity SGIIC, S.A. 1.6% -76% $3.14M -$6.88M 269K -68.6% Actyus Private Equity SGIIC, S.A. Sep 30, 2025

Institutional Holders of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.9M $20.8M +$5.12M $10.94 27
2025 Q2 1.45M $11.2M -$641K $7.72 21
2025 Q1 1.59M $9.8M +$7.01M $6.16 24
2024 Q4 454K $2.25M -$190K $5.10 17
2024 Q3 491K $2.48M -$395K $5.03 18
2024 Q2 649K $2.68M +$950K $4.11 19
2024 Q1 406K $3.07M +$531K $7.60 16
2023 Q4 333K $2.78M +$9.46K $8.34 17
2023 Q3 331K $2.8M +$382K $8.45 17
2023 Q2 286K $2.71M +$2.71M $9.50 15